What is Inspira Technologies Oxy B.H.N. Ltd. (IINNW)?

Inspira Technologies Oxy B.H.N. Ltd. (IINNW) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of IINNW?

The current price of IINNW is $0.14. Prices are updated in real time on Stocks360.

What is IINNW's price-to-earnings (PE) ratio?

IINNW's trailing twelve-month PE ratio is -0.31, based on current price and earnings per share data available on Stocks360.

What is IINNW's market capitalization?

IINNW's market capitalization is $3,412,608.00, placing it in the small-cap tier.

Inspira Technologies Oxy B.H.N. Ltd. (IINNW)

Stock analysis · NASDAQ · Healthcare · Medical - Devices

$0.14

Market Cap

$3.41M

PE (TTM)

-0.31

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

2.16

Day Range

$0.09 – $0.40

52-wk Range

$0.00 – $0.80

Avg Volume

N/A

Volume

4.14K

Inspira Technologies Oxy B.H.N. Ltd. (IINNW) is a publicly traded company in the Healthcare sector. Latest price: $0.14. Market cap $3.41M. Trailing PE -0.31. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 7 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $0.34 2026-05-19 · $0.14 (-57.61%)

Earnings

Most Recent

Mar 26, 2026

EPS $-0.21 vs est. $-0.20

Missed by $0.01

Proprietary Signals

Signal snapshot temporarily unavailable.

About Inspira Technologies Oxy B.H.N. Ltd.

Inspira Technologies Oxy B.H.N. Ltd. is a specialty medical device company dedicated to developing, manufacturing, and marketing innovative respiratory support technologies. Their core mission is to offer a non-invasive treatment alternative to traditional mechanical ventilation for individuals experiencing respiratory failure. The company's flagship product is the Augmented Respiration Technology (ART) system. This respiratory assistance device features a portable, minimally invasive dual-lumen cannula, which is inserted into the jugular vein. The ART system works by directly oxygenating blood outside the body (extracorporeal oxygenation), effectively elevating and stabilizing declining oxygen saturation levels. Originally incorporated in 2018 as Insense Medical Ltd., the company changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020 and is based in Ra'annana, Israel.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.31×
P/S (TTM)	11.81×
P/B	1.81×
P/FCF (TTM)	-0.34×
EV / EBITDA	-0.13×
EV / Sales	5.94×
Earnings Yield	-314.94%
Free Cash Flow Yield	-291.98%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$1.72M
Revenue (TTM)	$289.00K
Net Income (TTM)	-$10.75M
Free Cash Flow (TTM)	-$9.96M
Net Debt	-$1.70M
Working Capital	$1.59M
Gross Margin	-94.12%
Operating Margin	-4710.73%
Net Margin	-4574.39%
Return on Equity	-397.89%
Return on Invested Capital	-326.40%